->

Tag: Novartis Pharmaceuticals Corporation

Bogga Hore / Sanad La Aasaasay

, , , , , ,

Tisagenlecleucel waxa u ansixisay FDA dib u soo noqoshada ama limfoma follicular refractory

Juun 2022: Laba ama in ka badan oo daawaynta habaysan ka dib, FDA waxay siisay tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) oo dadajisay oggolaanshaha bukaanada qaangaarka ah ee dib u soo noqday ama dib u soo noqday follicular lymphoma (FL).T.

Bilow sheekada
Waxaan nahay Online! Nala hadal!
Sawir koodka
Hello,

Ku soo dhawoow CancerFax!

CancerFax waa madal horudhac ah oo u heellan in lagu xidho shakhsiyaadka wajahaya kansarka heerka sare ee daawaynta unugyada sida CAR T-Cell therapy, daawaynta TIL, iyo tijaabooyinka caafimaad ee adduunka oo dhan.

Nala soo socodsii waxaan kuu qaban karno.

1) Daaweynta kansarka ee dibadda?
2) CAR T-Cell therapy
3) Tallaalka kansarka
4) La-talinta fiidiyowga ee khadka tooska ah
5) daawaynta Proton